Diabetes Mellitus: all 11,090 studies
Page 77 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- The Practical Evidence of Antidiabetic Combination Therapy in KoreaCompletedNCT02231021Phase 4
- A Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT02230631
- Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in IndiaCompletedNCT02230618
- Intensive Case Diabetes Management (ICDM) to Prevent ReadmissionTerminatedNCT02230488Not applicable
- Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes MellitusWithdrawnNCT02229240Phase 3
- Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes PatientsCompletedNCT02229110Not applicable
- Utility of CrocsRx Clog as a Diabetic House Shoe: a Pilot StudyStatus unknownNCT02228629Not applicable
- A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 DiabetesCompletedNCT02227303Not applicable
- DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in JapanCompletedNCT02226822
- Uncovering the 'ORIGINS' of DiabetesCompletedNCT02226640
- Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.TerminatedNCT02225951Not applicable
- Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self CareStatus unknownNCT02225691Not applicable
- Trial to Incentivise Adherence for DiabetesCompletedNCT02224417Not applicable
- Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes MellitusCompletedNCT02224118Phase 1
- The Inova Type 2 Diabetes Mellitus StudyWithdrawnNCT02222623Not applicable
- Phase 2 Study of DS-8500a in Patients With Type 2 DiabetesCompletedNCT02222350Phase 2
- A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1CompletedNCT02221323Phase 2
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes MellitusCompletedNCT02220296Phase 1
- The Influence of Partial Remission Phase of Type 1 Diabetes on Patient OutcomeStatus unknownNCT02220257
- Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes PatientsCompletedNCT02219750Phase 4
- Diabetes & VardenafilCompletedNCT02219646Phase 2
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseCompletedNCT02218099Phase 1/2
- Edmonton Automated Sugar Intelligence - Intelligent Diabetes Management, EASI-IDM, App Program to Assist Diabetes CareCompletedNCT02214719Not applicable
- A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular DamageStatus unknownNCT02214654
- Resilient, Empowered, Active Living: REAL Diabetes StudyCompletedNCT02214641Not applicable
- Sensor-based Balance Training in Diabetes: A Virtual Reality ParadigmStatus unknownNCT02214329Not applicable
- A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesCompletedNCT02213146Phase 1/2
- Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500CompletedNCT02212951Phase 1/2
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 DiabetesTerminatedNCT02212925Phase 1
- Life Without DiabetesCompletedNCT02212665Not applicable
- Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early ComplicationsStatus unknownNCT02212522
- Diabetes Intervention Program for Adolescents With Persistent High HA1cStatus unknownNCT02212158Not applicable
- A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 DiabetesCompletedNCT02212067Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 DiabetesCompletedNCT02211963Phase 1
- Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)CompletedNCT02211651
- Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCompletedNCT02210871Phase 1
- Lifestyle Strategies for Improving Diabetes OutcomesStatus unknownNCT02210845Not applicable
- An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsCompletedNCT02208921
- Post-exercise Appetite Responses in Type 1 DiabetesCompletedNCT02208115Not applicable
- Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes MellitusWithdrawnNCT02206568Phase 1
- The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform ExerciseCompletedNCT02206074Not applicable
- The Effects of Hypoglycaemia in People With Type 2 DiabetesCompletedNCT02205996Not applicable
- A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT02205528Phase 2
- Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DMCompletedNCT02204839Not applicable
- Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 MelitisCompletedNCT02204397Phase 2
- Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes MellitusCompletedNCT02204384Not applicable
- Social Determinants in Chronic Disease in British ColumbiaCompletedNCT02203084
- Redox Imbalance and the Development of Cystic Fibrosis DiabetesCompletedNCT02202876Not applicable
- Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With LiraglutideCompletedNCT02201550
- TOFO Insulin Combination TrialCompletedNCT02201004Phase 4
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin GlargineCompletedNCT02200991Phase 4
- Impact of Individualized Structured Information Provision to the Patients, on Diabetes Related OutcomesCompletedNCT02200965Not applicable
- Forxiga Tablets Specific Clinical Experience Investigation for Long-term UseCompletedNCT02200666
- Forxiga Tablets Specific Clinical Experience Investigation for ElderlyCompletedNCT02200627
- Effect of Personalized Feedback Report and Peer Support on DiabetesCompletedNCT02199834Not applicable
- Reducing Type 2 Diabetes Diagnostic Delays Using Decision SupportCompletedNCT02199769Not applicable
- β-cell Function in Type 1 Diabetes May Not Be As Low As PresumedCompletedNCT02199470
- A Study to Compare Insulin Pump With Conventional Treatment in Type 2 DiabetesStatus unknownNCT02198846Not applicable
- Structured Aerobic and Resistance Exercise and Gestational DiabetesCompletedNCT02196571Not applicable
- Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)CompletedNCT02194608Not applicable
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)CompletedNCT02194595Phase 3
- Alliance to Control DiabetesStatus unknownNCT02193984Not applicable
- Correlation Between Plasma- and Endothelial DPP-4 ActivityCompletedNCT02192853Phase 4
- Insulin Degludec and Symptomatic Nocturnal HypoglycaemiaCompletedNCT02192450Phase 4
- Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)CompletedNCT02192424Phase 3
- SUPREME-DM (Diabetes Mellitis) Treatment StudyCompletedNCT02192255Not applicable
- Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 DiabetesCompletedNCT02191644Phase 2
- Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose ControlCompletedNCT02190669
- Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes CampCompletedNCT02189694Phase 2
- Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar LevelsCompletedNCT02189005Phase 3
- Effect of Gemigliptin on Metabolic Endotoxemia and LipemiaCompletedNCT02186080Not applicable
- Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 DiabetesCompletedNCT02185963Phase 4
- Internet Monitoring vs Medication to Control Blood Sugar in Type 2 DiabetesCompletedNCT02185755Not applicable
- Physician Led Counseling in Management of Depression in Type 2 Diabetes MellitusCompletedNCT02185482Not applicable
- Screening for GDM in Women With PCOS and ControlsCompletedNCT02183558Not applicable
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 DiabetesCompletedNCT02183415Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 DiabetesCompletedNCT02183350Phase 1
- BI 1356 BS in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02183324Phase 2
- Diabetes Mellitus After Intensive Care AdmissionStatus unknownNCT02180555
- The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin HormonesCompletedNCT02180334Phase 4
- Empowerment and Support for the Diabetic PatientStatus unknownNCT02179385Not applicable
- Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.CompletedNCT02178501Not applicable
- Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to MetforminStatus unknownNCT02177643Phase 2
- A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes MellitusCompletedNCT02175784Phase 4
- Reducing Distress And Improving Glycemic Control In Adults With Type 1 DiabetesCompletedNCT02175732Not applicable
- Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in QatarCompletedNCT02175537Not applicable
- Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal TherapyCompletedNCT02174146Not applicable
- Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes PatientsCompletedNCT02173457Phase 3
- Anesthesia With Epinephrine in Diabetes Patients is Safe and EffectiveCompletedNCT02173067
- Disruption of Immune Homeostasis in Type 2 Diabetics With Generalized Chronic PeriodontitisCompletedNCT02172716Not applicable
- Effect of Neuromuscular Electrostimulation on Sympathetic Nerve Activity in Patients With Type 2 Diabetes (ELECTROSYMP2)WithdrawnNCT02171351Not applicable
- Personalized Decision Support for Older Patients With DiabetesCompletedNCT02169999Not applicable
- Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary TuberculosisStatus unknownNCT02169570Phase 4
- Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes MellitusCompletedNCT02169531Phase 1
- Comparison of Resin Salve and Octenidine in Patients With Neuropathic Diabetic Foot UlcersCompletedNCT02169167Not applicable
- Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental IllnessCompletedNCT02167620Phase 4
- The Reach and Effectiveness of Technology-enhanced Diabetes Prevention ProgramsCompletedNCT02162901Not applicable
- Diabetic Shoulder MobilityCompletedNCT02162212Not applicable
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian SubjectsCompletedNCT02161588Phase 1
- Diabetes Incentive Performance Study (DIPS) at Shanghai Jiading DistrictStatus unknownNCT02161094Not applicable